Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)

V. Rossetti, S. Aliberti, P. Peyrani, F. M. Massari, F. Piffer, P. Castellotti, L. Ruvolo, M. Pappalettera, J. A. Ramirez, F. Blasi (Milan, Italy; Louisville, United States Of America)

Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Rossetti, S. Aliberti, P. Peyrani, F. M. Massari, F. Piffer, P. Castellotti, L. Ruvolo, M. Pappalettera, J. A. Ramirez, F. Blasi (Milan, Italy; Louisville, United States Of America). Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP). Eur Respir J 2009; 34: Suppl. 53, 2450

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
Source: Eur Respir J 2016; 47:1572-1574
Year: 2016


Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003

Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Influence of chronic cardiovascular diseases (CVD) on course and outcome of community-acquired pneumonia (CAP)
Source: International Congress 2017 – The acute patient: the clinical point-of-view
Year: 2017

Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018


Predictive factors of in-hospital mortality of patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006

Factors influencing in-hospital mortality in community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006

Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018




Incidence, risk factors and outcomes of nonresolving pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010

Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013



Risk contribution of comorbidities in hospitalized patients with Covid 19 pneumonia
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021


Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Treatment failure of community-acquired pneumonia: risk factors and consequences
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012

The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


The main risk factors of the community-acquired pneumonia delayed course
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005

Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009

Antibacterial therapy of community-acquired pneumonia (CAP) at patients with cardiovascular diseases (CVD)
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012


Risk factors of nosocomial pneumonia in multiple trauma patients
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2011; 39: 187-196
Year: 2012



Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2012; 39: 187-196
Year: 2012